Alliance Pharma PLC, an international healthcare group, has announced its total voting rights as of 31 October 2023. The company's issued share capital consists of 540,355,945 Ordinary Shares of 1p each. This figure will be used by shareholders to determine if they are required to notify any changes in their interest in the company under the FCA's Disclosure Guidance and Transparency Rules. Alliance Pharma aims to empower people to make a positive difference to their health and wellbeing by making their trusted and proven brands available worldwide. The company focuses on organic growth through investing in priority brands and channels, innovation, and selective geographic expansion. They may also consider complementary acquisitions to enhance their organic growth.